Home > Insider Trading > Filing (0001209191-23-051228)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1801777	Applied Molecular Transport Inc.	AMTI	Pharmaceutical Preparations (2834)	814481426

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1813219	Brandon Hants	C/O Applied Molecular Transport Inc. 450 East Jamie Court South San Francisco CA 94080	Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-09-28	491,111	$0.00	523,326	No	4	A	Direct
Common Stock	Disposition	2023-09-29	107,540	$0.16	415,786	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

The reported shares are represented by restricted stock units, or RSUs. 443,055 RSUs vested upon signing of the Agreement and Plan of Merger dated as of September 21, 2023, among Cyclo Therapeutics, Inc., a Nevada corporation, Cameo Merger Sub, Inc., a Delaware corporation and the Issuer (the "Merger Agreement"). The remaining 443,056 RSUs vest as to 50% on the date that is five trading days following the filing of the proxy/prospectus relating to stockholder approval of the merger contemplated by the Merger Agreement (the "Form S-4") and 50% on the date the Form S-4 is declared effective by the SEC.
Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of RSUs. This sale satisfies the minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the Reporting Person.
A portion of these securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.